RADNOR, Pa. (AP) — RADNOR, Pa. (AP) — Marinus Pharmaceuticals Inc. (MRNS) on Wednesday reported a loss of $38.7 million in its first quarter.

On a per-share basis, the Radnor, Pennsylvania-based company said it had a loss of 68 cents.

The results met Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was also for a loss of 68 cents per share.

The epilepsy drug developer posted revenue of $7.7 million in the period, which fell short of Street forecasts. Five analysts surveyed by Zacks expected $8.6 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNS at https://www.zacks.com/ap/MRNS